CSIMarket
 
Kalvista Pharmaceuticals Inc   (KALV)
 

News




KalVista Pharmaceuticals Evolving HAE Treatment with Real-World Data and Innovations

KalVista Pharmaceuticals Receives UK Designations and Presents Promising Data for Sebetralstat at AAAAI Annual Meeting

KalVista Pharmaceuticals Sets Promising New Paradigm in Hereditary Angioedema Treatment, Progressing with Clinical Trials and Achieving Financial Milestones

KalVista Pharmaceuticals Set to Present Promising HAE Attack Journey Data at 2024 HAEi Regional Conference Americas

KalVista Pharmaceuticals Appoints Benjamin L. Palleiko as CEO to Drive Growth and Overcome Challenges

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals Presents Encouraging Phase 3 KONFIDENT Trial Data for Sebetralstat at AAAAI Annual Meeting

Sebetralstat: KalVista Pharmaceuticals* UK Innovation Passport Grants Green Light for Breakthrough Hereditary Angioedema Treatment

Sebetralstat by KalVista Pharmaceuticals: A Game-Changer in Hereditary Angioedema Treatment

KalVista Pharmaceuticals Grants Inducement Options to New Employees: Assessing the Impact on Company Shares

Kalvista Pharmaceuticals Inc witnesses a substantial surge in business costs during the second quarter of 2024

Major Pharmaceutical Preparations Company, Kalvista Pharmaceuticals Inc, Faces Operating Deficit of $-29.093 Million in First Quarter of 2024

Among many companies, the Kalvista Pharmaceuticals Inc issued also the fourth quarter of 2023 numbers

The company published operating loss of $-25.883 millions, in the most recent fiscal period

Business expenses were on the rise at the company in the fiscal second quarter of 2023

Among many entities, the disclosed also the fourth quarter of 2022 results









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com